Detalhe da pesquisa
1.
Development of a complex Interdisciplinary Nurse-coordinated SELf-MAnagement (INSELMA) intervention for patients with inflammatory arthritis.
BMC Health Serv Res
; 24(1): 87, 2024 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38233834
2.
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
Ann Rheum Dis
; 82(10): 1286-1295, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423647
3.
Cytochrome P450 activity in rheumatoid arthritis patients during continuous IL-6 receptor antagonist therapy.
Eur J Clin Pharmacol
; 79(12): 1687-1698, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37831074
4.
Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset.
Ann Rheum Dis
; 81(8): 1085-1095, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35470158
5.
Musculoskeletal pain in psoriasis-relation to inflammation and additional value of ultrasound in psoriatic arthritis classification.
Rheumatology (Oxford)
; 61(7): 2835-2847, 2022 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34849603
6.
Pregnancy-related sacroiliac joint findings in females with low back pain: a four-year magnetic resonance imaging follow-up study.
Acta Radiol
; 63(6): 775-784, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34000822
7.
Prognostic value of the clinical and imaging arm of the ASAS criteria for progression of structural sacroiliac joint lesions.
Mod Rheumatol
; 2022 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36508308
8.
Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: nationwide observational study emulating a randomised clinical trial.
Ann Rheum Dis
; 80(11): 1400-1409, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33926921
9.
Impact of the COVID-19 pandemic on treat-to-target strategies and physical consultations in >7000 patients with inflammatory arthritis.
Rheumatology (Oxford)
; 60(SI): SI3-SI12, 2021 10 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34146099
10.
Predictors of joint damage progression and stringent remission in patients with established rheumatoid arthritis in clinical remission.
Rheumatology (Oxford)
; 60(1): 380-391, 2021 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929463
11.
Clinical and Magnetic Resonance Imaging Outcome Predictors in Pediatric Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Ann Neurol
; 88(1): 148-159, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32314416
12.
The utility of magnetic resonance imaging lesion combinations in the sacroiliac joints for diagnosing patients with axial spondyloarthritis. A prospective study of 204 participants including post-partum women, patients with disc herniation, cleaning staff, runners and healthy persons.
Rheumatology (Oxford)
; 59(11): 3237-3249, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32240310
13.
To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry.
Ann Rheum Dis
; 78(2): 192-200, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30396903
14.
Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical Trial.
JAMA
; 321(5): 461-472, 2019 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30721294
15.
Divergent effects on macrophage biomarkers soluble CD163 and CD206 in axial spondyloarthritis.
Scand J Clin Lab Invest
; 78(6): 483-489, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30176763
16.
A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry.
Ann Rheum Dis
; 76(8): 1426-1431, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28473425
17.
Mycobacterium alsense sp. nov., a scotochromogenic slow grower isolated from clinical respiratory specimens.
Int J Syst Evol Microbiol
; 66(1): 450-456, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26545358
18.
Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries.
Ann Rheum Dis
; 79(6): 846-848, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32111583
19.
Response to ''To switch or not to switch': the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al.
Ann Rheum Dis
; 79(4): e37, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30674476
20.
Response to: 'Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: possible fallout on non-medical switching' by Cantini and Benucci.
Ann Rheum Dis
; 79(2): e14, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30573653